NCT07630259

Brief Summary

The goal of this clinical trial was to determine whether high-intensity laser therapy (HILT) combined with exercise improves pain, physical function, and muscle strength in people with knee osteoarthritis. The main questions the study aimed to answer were:

  • Did HILT combined with exercise lower pain more than sham laser combined with exercise?
  • Did HILT combined with exercise improve physical function more than sham laser combined with exercise?
  • Did HILT combined with exercise improve knee extensor muscle strength more than sham laser combined with exercise? Researchers compared HILT plus exercise with sham laser plus exercise to determine whether HILT provided additional benefits beyond those achieved with exercise alone. Participants:
  • Received either HILT or sham laser treatment for four weeks.
  • Participated in a standardized exercise program.
  • Completed assessments of pain, physical function, and muscle strength before and after treatment.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
31

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Nov 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 29, 2023

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 26, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 26, 2025

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

June 1, 2026

Completed
4 days until next milestone

First Posted

Study publicly available on registry

June 5, 2026

Completed
Last Updated

June 5, 2026

Status Verified

June 1, 2026

Enrollment Period

1.7 years

First QC Date

June 1, 2026

Last Update Submit

June 1, 2026

Conditions

Keywords

Knee OsteoarthritisHigh Intensity Laser TherapyHILTLaser TherapyPhotobiomodulationPainExcercise TherapyRehabilitationMúsculo StrengthPhysical FunctionMusculoskeletal DisordersRandomized Controlled Trial

Outcome Measures

Primary Outcomes (1)

  • Change From Baseline in Knee Extensor Muscle Strength After 4 Weeks of Treatment

    Change in knee extensor muscle strength measured with a dynamometer. Results were expressed in Newtons (N). Higher values indicate greater muscle strength.

    Baseline and Week 4

Secondary Outcomes (2)

  • Change From Baseline in Pain Intensity After 4 Weeks of Treatment

    Baseline and Week 4

  • Change From Baseline in WOMAC Total Score After 4 Weeks of Treatment

    Baseline and Week 4

Study Arms (2)

High Intensity Laser Therapy + Exercise

EXPERIMENTAL

Participants received high-intensity laser therapy (HILT) combined with a standardized exercise program. HILT was delivered using an MLS laser device (MPHI D, ASA Laser, Italy) over four periarticular knee application points during 10 treatment sessions over four weeks. The exercise program included strengthening, flexibility, and balance exercises and was identical to that provided to the sham comparator group.

Device: High Intensity Laser TherapyOther: Exercise

Sham Laser + Exercise

SHAM COMPARATOR

Participants received sham laser treatment combined with the same standardized exercise program used in the experimental group. Sham treatment was delivered using the same laser device and treatment schedule as the active intervention but with subtherapeutic parameters designed to maintain participant blinding. The intervention consisted of 10 treatment sessions over four weeks. The exercise program included strengthening, flexibility, and balance exercises.

Device: Sham LaserOther: Exercise

Interventions

High-intensity laser therapy (HILT) was delivered using an MLS laser device (MPHI D, ASA Laser, Italy), which combines synchronized 808 nm and 905 nm wavelengths. Treatment was applied to four periarticular knee regions, including the medial and lateral patellar borders, the suprapatellar region, and the medial tibiofemoral joint line. Participants received 10 treatment sessions over four weeks. HILT was administered in combination with a standardized exercise program.

Also known as: HILT, MLS Laser Therapy, Photobiomodulation, Laser Therapy
High Intensity Laser Therapy + Exercise

Sham laser treatment was delivered using the same laser device, treatment schedule, and application sites as the active intervention. Subtherapeutic parameters were used to mimic the treatment procedure while minimizing biological effects and maintaining participant blinding. Participants received 10 treatment sessions over four weeks in combination with the same standardized exercise program used in the experimental group.

Also known as: Sham Laser Therapy, Placebo Laser, Sham High Intensity Laser Therapy
Sham Laser + Exercise

The exercise program was performed during each treatment session and included strengthening, flexibility, and balance exercises targeting the lower extremities. Exercises included stationary cycling, hamstring and gastrocnemius stretching, straight-leg raises, knee extensions, heel raises, step-ups, and single-leg balance activities. The program was standardized for both study groups and was delivered over 10 sessions during a four-week period.

Also known as: Therapeutic exercise, Exercise Program, Physical Therapy exercise, Rehabilitation exercise
High Intensity Laser Therapy + ExerciseSham Laser + Exercise

Eligibility Criteria

Age45 Years - 77 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Clinical diagnosis of knee osteoarthritis.
  • Age between 45 and 77 years.
  • Pain intensity of at least 3 points on the Visual Analogue Scale (VAS).

You may not qualify if:

  • Presence of other musculoskeletal conditions affecting the lower limbs.
  • History of lower limb surgery.
  • Tattoos in the laser application area.
  • Recent intra-articular corticosteroid injection.
  • Comorbidities limiting participation in physical exercise, such as chronic obstructive pulmonary disease, stroke, or severe heart failure.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Departamento de Kinesiología

Santiago, Santiago Metropolitan, 7760197, Chile

Location

Related Publications (4)

  • Jang S, Lee K, Ju JH. Recent Updates of Diagnosis, Pathophysiology, and Treatment on Osteoarthritis of the Knee. Int J Mol Sci. 2021 Mar 5;22(5):2619. doi: 10.3390/ijms22052619.

    PMID: 33807695BACKGROUND
  • Siriratna P, Ratanasutiranont C, Manissorn T, Santiniyom N, Chira-Adisai W. Short-Term Efficacy of High-Intensity Laser Therapy in Alleviating Pain in Patients with Knee Osteoarthritis: A Single-Blind Randomised Controlled Trial. Pain Res Manag. 2022 Oct 21;2022:1319165. doi: 10.1155/2022/1319165. eCollection 2022.

    PMID: 36313402BACKGROUND
  • Akaltun MS, Altindag O, Turan N, Gursoy S, Gur A. Efficacy of high intensity laser therapy in knee osteoarthritis: a double-blind controlled randomized study. Clin Rheumatol. 2021 May;40(5):1989-1995. doi: 10.1007/s10067-020-05469-7. Epub 2020 Oct 19.

    PMID: 33074393BACKGROUND
  • Song HJ, Seo HJ, Kim D. Effectiveness of high-intensity laser therapy in the management of patients with knee osteoarthritis: A systematic review and meta-analysis of randomized controlled trials. J Back Musculoskelet Rehabil. 2020;33(6):875-884. doi: 10.3233/BMR-191738.

    PMID: 32831189BACKGROUND

MeSH Terms

Conditions

OsteoarthritisOsteoarthritis, KneePainMusculoskeletal Diseases

Interventions

Low-Level Light TherapyLaser TherapyExerciseExercise TherapyResistance Training

Condition Hierarchy (Ancestors)

ArthritisJoint DiseasesRheumatic DiseasesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

TherapeuticsPhototherapyAblation TechniquesSurgical Procedures, OperativeMotor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological PhenomenaRehabilitationAftercareContinuity of Patient CarePatient CarePhysical Therapy ModalitiesPhysical Conditioning, Human

Study Officials

  • Ivan Patricio Silva-Satlov, Magister

    Universidad Metropolitana de Ciencias de la Educación

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor and Principal Investigator

Study Record Dates

First Submitted

June 1, 2026

First Posted

June 5, 2026

Study Start

November 29, 2023

Primary Completion

August 26, 2025

Study Completion

August 26, 2025

Last Updated

June 5, 2026

Record last verified: 2026-06

Data Sharing

IPD Sharing
Will share

De-identified individual participant data underlying the results reported in publications arising from this study will be available upon reasonable request. Data that support the primary and secondary outcome analyses, including pain, functional status, and muscle strength measurements, may be shared after publication of the primary study results. Requests will be evaluated by the Principal Investigator and must include a scientifically sound research proposal. All shared data will be fully de-identified to protect participant confidentiality.

Shared Documents
STUDY PROTOCOL, SAP, ICF
Time Frame
Individual participant data and supporting documents will be available beginning 6 months after publication of the primary study results and will remain available for 5 years thereafter.
Access Criteria
Researchers who provide a methodologically sound research proposal may request access to de-identified individual participant data and supporting documents. Requests should be directed to the Principal Investigator. Data will be shared only after review and approval of the proposed use and may require a data sharing agreement to protect participant confidentiality and ensure appropriate use of the data.

Locations